Abstract
Vast quantities of Magnetic Resonance Images (MRI) are routinely acquired in clinical practice but, to speed up acquisition, these scans are typically of a quality that is sufficient for clinical diagnosis but sub-optimal for large-scale precision medicine, computational diagnostics, and large-scale neuroimaging research. Here, we present a critic-guided framework to upsample low-resolution (often 2D) MRI scans. In addition, we incorporated feature-importance and self-attention methods into our model to improve the interpretability of this work. We evaluate our framework on paired low- and high-resolution brain MRI structural full scans (i.e. T1-, T2-weighted and FLAIR sequences are simultaneously input) obtained in clinical and research settings from scanners manufactured by Siemens, Phillips and GE. We showed that the upsampled MRIs are qualitatively faithful to the ground-truth high-quality scans (PSNR = 35.39; MAE = 3.78E −3; NMSE = 4.32E −10; SSIM = 0.9852; mean normal-appearing grey/white matter ratio intensity differences ranging from 0.0363 to 0.0784 for FLAIR, from 0.0010 to 0.0138 for T1-weighted and from 0.0156 to 0.074 for T2-weighted sequences). The automatic raw segmentations of tissues and lesions using the super-resolved images have fewer false positives and higher accuracy than those obtained from interpolated images in protocols represented with more than three sets in the training sample, making our approach a strong candidate for practical application in clinical research.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
BML and LVC are supported by the United Kingdom Research and Innovation (grant EP/S02431X/1), UKRI Centre for Doctoral Training in Biomedical AI at the University of Edinburgh, School of Informatics. YC is supported by the China Scholarship Council. MCVH is funded by the Row Fogo Charitable Trust Grant no. BRO-D.FID3668413. SJW is funded by the Stroke Association Post-Doctoral Fellowship (SAPDF 18/ 100026). This work is also partially funded by the Selfridges Group Foundation under the Novel Biomarkers 2019 scheme (ref UB190097) administered by the Weston Brain Institute, and the Fondation Leducq Transatlantic Network of Excellence for the Study of Perivascular Spaces in Small Vessel Disease, ref no. 16 CVD 05. UC is funded by the Stroke Association Princess Margaret Research Development Fellowship 2018. FND is funded by the Stroke Association Garfield Weston Foundation Senior Clinical Lectureship(TSALECT 2015/04). DJG is Funded by the Wellcome Trust. The images used in this study were funded by the UK Dementia Research Institute which receives its funding from DRI Ltd, funded by the UK MRC, Alzheimer's Society and Alzheimer's Research UK. The 3T MRI Research scanner at The Royal Infirmary of Edinburgh, where the high-resolution images were acquired, is funded by the Wellcome Trust (104916/Z/14/Z), Dunhill Trust (R380R/1114), Edinburgh and Lothians Health Foundation (2012/17), Muir Maxwell Research Fund, Edinburgh Imaging, and The University of Edinburgh.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The ethics committee/IBR of the Centre for Clinical Brain Sciences at the University of Edinburgh and the Stroke Clinic at NHS Lothian gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All numerical data will be available upon publication.
